Aethlon Medical (NASDAQ:AEMD) Issues Quarterly Earnings Results

Aethlon Medical (NASDAQ:AEMD) released its earnings results on Thursday. The medical equipment provider reported ($0.91) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.18) by $0.27, Zacks reports. During the same period last year, the firm posted ($1.10) EPS.

Aethlon Medical Trading Down 13.8 %

Shares of NASDAQ:AEMD traded down $0.08 during trading on Friday, hitting $0.50. 1,707,769 shares of the stock were exchanged, compared to its average volume of 11,476,545. The company has a fifty day moving average price of $0.78 and a two-hundred day moving average price of $1.44. The company has a market cap of $1.31 million, a PE ratio of -0.10 and a beta of 1.60. Aethlon Medical has a 12-month low of $0.37 and a 12-month high of $5.00.

Analyst Ratings Changes

Several equities analysts have issued reports on AEMD shares. HC Wainwright dropped their target price on Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, June 24th. StockNews.com initiated coverage on Aethlon Medical in a research report on Sunday, June 23rd. They set a “sell” rating on the stock.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.